David James Vaughan Insider Profile
4 Followers
David James Vaughan, former Chief Development Officer at Antibe Therapeutics, holds 26.66K shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, David James Vaughan Bought 17,551 shares of Antibe Therapeutics on Jun 07, 2021 for an estimated value of $77.64K.
David James Vaughan's Trading History
| ATBPFAntibe Therapeutics | Jun 07, 2021 | ― | Informative Buy | 77.64K | $5.73K | |||||||||||||||||||||||||||||||||||||||||||
ATBPF
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
David James Vaughan insider profile FAQ
What is the percentage of profitable transactions made by David James Vaughan?
The percentage of profitable transactions made by David James Vaughan is 38%.
What is the average return per transaction made by David James Vaughan?
The average return per transaction made by David James Vaughan is -41.20%.
What stocks does David James Vaughan hold?
David James Vaughan holds: ATBPF stocks.
What was David James Vaughan’s latest transaction?
David James Vaughan’s latest transaction was an Informative Buy of $77.64K.
What was David James Vaughan's most profitable transaction?
David James Vaughan’s most profitable transaction was an Informative Sell of ATBPF stock on April 30, 2018. The return on the trade was 23.90%.
What is David James Vaughan's role in Antibe Therapeutics?
David James Vaughan's role in Antibe Therapeutics is Chief Development Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
